At a glance
- Originator Pfizer
- Class Dioxoles; Heart failure therapies; Thiazines
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Pulmonary hypertension
Most Recent Events
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 28 Sep 1999 Preclinical development for Congestive heart failure in USA (Unknown route)
- 28 Sep 1999 Preclinical development for Pulmonary hypertension in USA (Unknown route)